A detailed history of Ubs Asset Management Americas Inc transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 111,791 shares of CLBT stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,791
Previous 100,061 11.72%
Holding current value
$2.26 Million
Previous $1.2 Million 57.49%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.61 - $17.52 $136,185 - $205,509
11,730 Added 11.72%
111,791 $1.88 Million
Q2 2024

Aug 13, 2024

BUY
$10.38 - $12.5 $660,801 - $795,762
63,661 Added 174.89%
100,061 $1.2 Million
Q1 2022

May 16, 2022

BUY
$5.34 - $8.12 $28,836 - $43,847
5,400 Added 17.42%
36,400 $232,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $11.24 $241,800 - $348,440
31,000 New
31,000 $248,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.83B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.